AMH Equity »

BioCryst Pharmaceuticals shares owned by AMH Equity

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by AMH Equity from 13F filings

Historical chart of AMH Equity investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by AMH Equity consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by AMH Equity

Quarter filed Position value Share count Share price at filing
2024-09-30 $760k 100k 7.60

More positions owned by AMH Equity

Twin Disc, Incorporated (TWIN)
Universal Electronics (UEIC)
Harvard Bioscience (HBIO)
Powerfleet (AIOT)
Algoma Stl Group (ASTL)
Thermon Group Holdings (THR)
Lightpath Technologies Com Cl A (LPTH)
Amphenol Corp Cl A Put Option (APH)
Brady Corp Cl A (BRC)
Ionq Inc Pipe (IONQ)
Cvd Equipment Corp equity (CVV)
Amtech Sys Com Par $0.01n (ASYS)
Moneylion Cl A (ML)
Iheartmedia Com Cl A (IHRT)
Biodesix (BDSX)

View all positions for AMH Equity

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Kynam Capital Management
State Street Corporation
Deerfield Management Company
Alkeon Capital Management
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group

View all funds holding BioCryst Pharmaceuticals